Evidence map›Paper›PMID 36352045›Full record

ArticleScientific reports2022

Machine learning-based detection of label-free cancer stem-like cell fate.

Alexis J Chambost, Nabila Berabez, Olivier Cochet-Escartin, François Ducray, Mathieu Gabut, Caroline Isaac, Sylvie Martel, Ahmed Idbaih, David Rousseau, David Meyronet and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Cancer Stem Cells from Definition to Detection and Targeted Drugs.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Alexis J ChambostCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Nabila BerabezCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Olivier Cochet-EscartinUniv Lyon, CNRS, Institut Lumière Matière, Univ Claude Bernard Lyon 1, 69622, Villeurbanne, France.
François DucrayCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Mathieu GabutCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Caroline IsaacCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Sylvie MartelCancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Ahmed IdbaihInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Sorbonne Université, Paris, France.
David Rousseau *Laboratoire Angevin de Recherche en Ingénierie des Systèmes (LARIS), UMR Inrae IRHS, Université d'Angers, 49000, Angers, France. david.rousseau@univ-angers.fr.
David Meyronet *Cancer Initiation and Tumor Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, Villeurbanne, France.
Sylvain Monnier *Univ Lyon, CNRS, Institut Lumière Matière, Univ Claude Bernard Lyon 1, 69622, Villeurbanne, France. sylvain.monnier@univ-lyon1.fr.
Centre National de la Recherche Scientifique · FRInstitut Lumière Matière · FRUniversité Claude Bernard Lyon 1 · FRCentre de Recherche en Cancérologie de Lyon · FRHospices Civils de Lyon · FRInserm · FRLaboratoire Angevin de Recherche en Mathématiques · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of cancer stem-like cells (CSCs) is mainly based on molecular markers or functional tests giving a posteriori results. Therefore label-free and real-time detection of single CSCs remains a difficult challenge. The recent development of microfluidics has made it possible to perform high-throughput single cell imaging under controlled conditions and geometries. Such a throughput requires adapted image analysis pipelines while providing the necessary amount of data for the development of machine-learning algorithms. In this paper, we provide a data-driven study to assess the complexity of brightfield time-lapses to monitor the fate of isolated cancer stem-like cells in non-adherent conditions. We combined for the first time individual cell fate and cell state temporality analysis in a unique algorithm. We show that with our experimental system and on two different primary cell lines our optimized deep learning based algorithm outperforms classical computer vision and shallow learning-based algorithms in terms of accuracy while being faster than cutting-edge convolutional neural network (CNNs). With this study, we show that tailoring our deep learning-based algorithm to the image analysis problem yields better results than pre-trained models. As a result, such a rapid and accurate CNN is compatible with the rise of high-throughput data generation and opens the door to on-the-fly CSC fate analysis.

Indexed as

NeoplasmsAlgorithmsHumansImage Processing, Computer-AssistedMachine LearningNeural Networks, Computer

Identifiers

PMID36352045
PMCPMC9646748
OpenAlexW4308738320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.